February 14th 2017 Canopy Growth Corp. Canopy Growth after its bull run last week is now in a pullback after its earnings report hit this morning. The pre market bid for WEED was at $13.25 CAD and quickly at...
TORONTO, ONTARIO–(Marketwired – Feb. 14, 2017) – NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE:MJN) (“Cronos” or the “Company”) is pleased to announce that...
Potential Catalysts for Cronos Group Improvement Of / Growth In Peace Naturals. Since acquiring control, the company has made many operational changes (increased power and growing capacity, optimized production methodologies and facility layout, overhauled retail pricing strategy, established...
February 13, 2017 Cronos Group (MJN:TSXV) is poised to take off for 2017. This is a speculative opinion of course but if we look at Cronos Group objectively we can see that they have positioned themselves to be set for when legalization rolls...
TORONTO, ON–(Marketwired – January 23, 2017) PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) (“Cronos” or the “Company”), seeks shareholder approval to formally change its name to “Cronos Group Inc.” following the corporate rebranding announced on October 6,...
TORONTO, ON–(Marketwired – January 19, 2017) – PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) (“Cronos” or the “Company”), is pleased to announce that the German parliament has expanded its medical marijuana program. In a landmark bill, members...
TORONTO, ON–(Marketwired – January 11, 2017) – NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) (“Cronos” or the “Company”), is pleased to announce that the Company’s...
TORONTO, ON – (Marketwired – December 28, 2016) PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) (“Cronos” or “the Company”), is pleased to announce the execution of an exclusive supply agreement with German-based Pedanios GmbH (“Pedanios”) for the...
TORONTO, ON–(Marketwired – December 13, 2016) – PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) (“Cronos” or “the Company”), is pleased with and supportive of the recommendations provided in the report by the Task Force on Cannabis Legalization...
TORONTO, ON –November 29, 2016 NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE PharmaCan Capital Corp., doing business as Cronos Group (TSXV:MJN) (“Cronos” or the “Company”) is pleased to provide the first operational update related to its...
